New Listing: Mankind Pharma makes stellar debut, lists at ₹1300, over 20% premium to issue price
Mankind Pharma IPO subscribed 15.32 times on last day of offer
Mankind Pharma IPO receives 87% subscription on Day 2; QIB portion booked 1.86 times